← Product Code [DAC](/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DAC) · K891904

# EZ COMPLEMENT C1 (K891904)

_Diamedix Corp. · DAC · Apr 14, 1989 · Immunology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DAC/K891904

## Device Facts

- **Applicant:** Diamedix Corp.
- **Product Code:** [DAC](/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DAC.md)
- **Decision Date:** Apr 14, 1989
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 866.5260
- **Device Class:** Class 2
- **Review Panel:** Immunology

## Regulatory Identification

A complement C3b inactivator immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the complement C3b inactivator (a plasma protein) in serum. Complement is a group of serum proteins that destroy infectious agents. Measurement of complement C3b inactivator aids in the diagnosis of inherited antibody dysfunction.

---

**Source:** [https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DAC/K891904](https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DAC/K891904)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com